HTSUF
Price
$29.00
Change
+$0.06 (+0.21%)
Updated
Aug 21 closing price
Capitalization
2.09B
INDV
Price
$24.74
Change
-$0.24 (-0.96%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
3.09B
44 days until earnings call
Interact to see
Advertisement

HTSUF vs INDV

Header iconHTSUF vs INDV Comparison
Open Charts HTSUF vs INDVBanner chart's image
Hisamitsu Pharmaceutical
Price$29.00
Change+$0.06 (+0.21%)
Volume$100
Capitalization2.09B
Indivior
Price$24.74
Change-$0.24 (-0.96%)
Volume$43.86K
Capitalization3.09B
HTSUF vs INDV Comparison Chart in %
Loading...
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HTSUF vs. INDV commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HTSUF is a Hold and INDV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (HTSUF: $29.00 vs. INDV: $24.98)
Brand notoriety: HTSUF and INDV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HTSUF: 100% vs. INDV: 115%
Market capitalization -- HTSUF: $2.09B vs. INDV: $3.09B
HTSUF [@Pharmaceuticals: Generic] is valued at $2.09B. INDV’s [@Pharmaceuticals: Generic] market capitalization is $3.09B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.25B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HTSUF’s FA Score shows that 0 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • HTSUF’s FA Score: 0 green, 5 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than HTSUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HTSUF’s TA Score shows that 2 TA indicator(s) are bullish while INDV’s TA Score has 2 bullish TA indicator(s).

  • HTSUF’s TA Score: 2 bullish, 2 bearish.
  • INDV’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, HTSUF is a better buy in the short-term than INDV.

Price Growth

HTSUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.30%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +86.94%.

Reported Earning Dates

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.30% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($3.09B) has a higher market cap than HTSUF($2.09B). INDV has higher P/E ratio than HTSUF: INDV (30.54) vs HTSUF (16.04). INDV YTD gains are higher at: 100.965 vs. HTSUF (18.083). HTSUF has higher annual earnings (EBITDA): 26.4B vs. INDV (261M). HTSUF has more cash in the bank: 123B vs. INDV (510M). INDV has less debt than HTSUF: INDV (366M) vs HTSUF (1.12B). HTSUF has higher revenues than INDV: HTSUF (150B) vs INDV (1.17B).
HTSUFINDVHTSUF / INDV
Capitalization2.09B3.09B68%
EBITDA26.4B261M10,115%
Gain YTD18.083100.96518%
P/E Ratio16.0430.5453%
Revenue150B1.17B12,788%
Total Cash123B510M24,118%
Total Debt1.12B366M305%
FUNDAMENTALS RATINGS
HTSUF vs INDV: Fundamental Ratings
HTSUF
INDV
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
6947
SMR RATING
1..100
8377
PRICE GROWTH RATING
1..100
5535
P/E GROWTH RATING
1..100
75100
SEASONALITY SCORE
1..100
5585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HTSUF's Valuation (91) in the null industry is in the same range as INDV (94). This means that HTSUF’s stock grew similarly to INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (47) in the null industry is in the same range as HTSUF (69). This means that INDV’s stock grew similarly to HTSUF’s over the last 12 months.

INDV's SMR Rating (77) in the null industry is in the same range as HTSUF (83). This means that INDV’s stock grew similarly to HTSUF’s over the last 12 months.

INDV's Price Growth Rating (35) in the null industry is in the same range as HTSUF (55). This means that INDV’s stock grew similarly to HTSUF’s over the last 12 months.

HTSUF's P/E Growth Rating (75) in the null industry is in the same range as INDV (100). This means that HTSUF’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HTSUFINDV
RSI
ODDS (%)
Bearish Trend 4 days ago
25%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
25%
Bearish Trend 4 days ago
54%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
12%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
15%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 7 days ago
57%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVEIX10.170.08
+0.79%
Macquarie Climate Solutions I
LCBSX57.52-0.06
-0.10%
ClearBridge Select FI
RGGIX47.34-0.07
-0.15%
T. Rowe Price Global Growth Stock I
LMUSX26.71-0.07
-0.26%
Franklin U.S. Large Cap Equity FI
PRGFX116.56-0.41
-0.35%
T. Rowe Price Growth Stock

HTSUF and

Correlation & Price change

A.I.dvisor tells us that HTSUF and INIS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUF and INIS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUF
1D Price
Change %
HTSUF100%
N/A
INIS - HTSUF
10%
Poorly correlated
N/A
INDV - HTSUF
5%
Poorly correlated
+1.01%
IPSEF - HTSUF
4%
Poorly correlated
N/A
GTBIF - HTSUF
3%
Poorly correlated
+4.55%
HLTRF - HTSUF
1%
Poorly correlated
N/A
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and ALKS have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and ALKS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+1.01%
ALKS - INDV
25%
Poorly correlated
+3.53%
COLL - INDV
24%
Poorly correlated
-2.32%
HROW - INDV
24%
Poorly correlated
+2.18%
VTRS - INDV
23%
Poorly correlated
+1.65%
AMRX - INDV
23%
Poorly correlated
+0.73%
More